Customize
Quick Links
Specialties

Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Bristol-Myers Squibb, Incyte Corporation, and Mallinckrodt Pharmaceuticals, Inc.

Medical Crossfire®: New Frontiers in the Management of GvHD: Uncovering the Latest Advances to Improve Post-Transplant Care

Release Date: May 31, 2018
Expiration Date: May 31, 2019
Media: Internet - based

 

Medical Crossfire® Overview

Medical Crossfire®: New Frontiers in the Management of GvHD: Uncovering the Latest Advances to Improve Post-Transplant Care features 4 faculty members who are experts in treating patients with graft-vs-host disease (GvHD). This online continuing medical education activity includes a discussion of the differences between acute and chronic GvHD and the associated treatment challenges and controversies. A thought-provoking case study is also presented to demonstrate individualized care in patients with GvHD.

Those who participate in this program should be better prepared to:

  • Describe the biologic phases of chronic GvHD
  • Identify common risk factors for GvHD
  • Review current and emerging treatment options a patient with GvHD
  • Identify patients with GvHD who should be encouraged to enroll in a clinical trial

 

Acknowledgement of Commercial Support

This activity is supported by educational grants from Bristol-Myers Squibb, Incyte Corporation, and Mallinckrodt Pharmaceuticals, Inc.

Requirements for Successful Completion

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “educational content/video” will be available for your reference.
  • In order to receive a CME certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME certificate upon completion of these steps.


Target Audience for Medical Crossfire®: New Frontiers in the Management of GvHD: Uncovering the Latest Advances to Improve Post-Transplant Care

This educational activity is directed toward medical oncologists, hematologists, and fellows who treat patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of hematologic malignancies are also invited to participate.

Learning Objectives

At the conclusion of this activity, you should be better prepared to:

  • Explain the pathogenesis of GvHD and guidelines to assess, stage, and manage patients with GvHD
  • Describe methods to prevent the occurrence of GvHD in the care of patients who undergo hematopoietic stem cell transplantation
  • Assess recent results concerning emerging therapies for GvHD management, and place this evidence into the context of evolving treatment standards
  • Detail evolving biomarkers that can facilitate the identification of chronic GvHD and the probability of response to current and emerging targeted strategies


Faculty, Staff, and Planners' Disclosures

Moderator

Corey Cutler, MD, MPH, FRCP(C)
Associate Professor of Medicine
Harvard Medical School
Division of Hematologic Oncology
Dana-Farber Cancer Institute
Boston, MA

Disclosure: Consultant: Pfizer, Incyte, Kalytera, Cellect Bio, Pharmacyclics, Elsalys, Fate, BMS, Kadmon; Speakers Bureau: prIME Oncology, i3 Health

Faculty

James Ferrara, MD, DSc
Ward-Coleman Chair in Cancer Medicine
Director, Hematologic Malignancies Translational Research Center
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
New York, NY
 

Disclosure: Consultant: VIRACOR; Other: Intellectual Property (Patent) Rights to use of biomarkers for GvHD

Muna Qayed, MD, MSc
Associate Professor of Pediatrics
Emory University
Clinical Director, Cell and Gene Therapy Program
Children’s Healthcare of Atlanta
Atlanta, GA

Disclosure: Dr. Qayed has no relevant financial relationships with commercial interests to disclose.

Nelson Chao, MD, MBA
Donald D. and Elizabeth G. Cooke Professor
Professor of Medicine/Immunology/Pathology
Chief, Division of Hematologic Malignancies and Cellular Therapy/BMT
Director, Global Cancer
Duke Global Health Institute
Durham, NC

Disclosure: Dr. Chao has no relevant financial relationships with commercial interests to disclose.

The staff of Physicians' Education Resource®, LLC have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing education purposes only, and is not meant to substitute for the independent medical judgment of a physician or nurse relative to diagnostic, treatment, or management options for a specific patient's medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any of the companies that provided commercial support for this activity.







Become a Member

Forgot Password?
Filter By